Embed Size (px)
Citation preview
Slide 1
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Acknowledgements
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Conflicts of interests
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Pseudoprogression
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Case study: 48 y.o. female presented with several day history of increasing left arm and lower facial weakness<br />
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Perfusion MRI appears to solve this diagnostic dilemma
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Pseudoprogession assessed with ferumoxytol
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Ferumoxytol- an iron oxide nanoparticle
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Separation of intravascular and parenchymal contrast enhancement
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 10
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 11
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 12
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Diagnosis of pseudoprogression
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Methods
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 15
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 16
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 17
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Rate of pseudoprogression
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 19
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 20
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Ferumoxytol as MRI contrast agent: orphan-drug designation<br />
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Slide 22
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Take home message
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
Thank you for your attention!
Presented By Edward Neuwelt at 2014 ASCO Annual Meeting
